Peter J. Schwartz

Peter J. Schwartz's AcademicInfluence.com Rankings

Peter J. Schwartz

Computer Science

#2224

World Rank

#2316

Historical Rank

Computational Linguistics

#23

World Rank

#23

Historical Rank

Machine Learning

#114

World Rank

#115

Historical Rank

Database

#204

World Rank

#212

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Peter J. Schwartz's Degrees

PhD Computer Science Stanford University
Masters Computer Science University of California, Berkeley
Bachelors Computer Science University of California, Berkeley

Similar Degrees You Can Earn

Why Is Peter J. Schwartz Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Peter J. Schwartz's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Heart rate variability. Standards of measurement, physiological interpretation, and clinical use (1996) (15801)
Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. (1996) (14574)
Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction (1998) (3044)
Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias (1996) (1740)
Genotype-Phenotype Correlation in the Long-QT Syndrome: Gene-Specific Triggers for Life-Threatening Arrhythmias (2001) (1679)
HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. (2013) (1519)
CaV1.2 Calcium Channel Dysfunction Causes a Multisystem Disorder Including Arrhythmia and Autism (2004) (1450)
Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction (1996) (1326)
Spectrum of Mutations in Long-QT Syndrome Genes: KVLQT1, HERG, SCN5A, KCNE1, and KCNE2 (2000) (1248)
Diagnostic Criteria for the Long QT Syndrome An Update (1993) (1164)
The Long QT Syndrome: Prospective Longitudinal Study of 328 Families (1991) (945)
Task Force on Sudden Cardiac Death of the European Society of Cardiology. (2001) (929)
Low penetrance in the long-QT syndrome: clinical impact. (1999) (862)
Prevalence of the Congenital Long-QT Syndrome (2009) (859)
Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. (1995) (780)
Pathophysiology and Prevention of Atrial Fibrillation (2001) (756)
Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. (2000) (734)
Influence of the genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. (1998) (728)
Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. (1992) (724)
HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes (2013) (720)
The long Q-T syndrome. (1975) (714)
Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials (2001) (683)
Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarction. A prospective study. (1988) (677)
Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. (1991) (673)
Risk stratification in the long-QT syndrome. (2003) (670)
Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS. (1996) (654)
Recommendations for interpretation of 12-lead electrocardiogram in the athlete. (2009) (648)
Idiopathic long QT syndrome: progress and questions. (1985) (646)
Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. (1988) (619)
Left Cardiac Sympathetic Denervation in the Management of High-Risk Patients Affected by the Long-QT Syndrome (2004) (617)
QT interval prolongation as predictor of sudden death in patients with myocardial infarction. (1978) (608)
ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. (1995) (599)
Allelic Variants in Long-QT Disease Genes in Patients With Drug-Associated Torsades de Pointes (2002) (562)
Prevalence of Long-QT Syndrome Gene Variants in Sudden Infant Death Syndrome (2007) (543)
Electrical alternation of the T-wave: clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q-T syndrome. (1975) (532)
A sympathetic reflex elicited by experimental coronary occlusion. (1969) (522)
Association of Long QT Syndrome Loci and Cardiac Events Among Patients Treated With β-Blockers (2004) (520)
A common polymorphism associated with antibiotic-induced cardiac arrhythmia. (2000) (487)
Clinical and Genetic Heterogeneity of Right Bundle Branch Block and ST-Segment Elevation Syndrome: A Prospective Evaluation of 52 Families (2000) (485)
The long QT syndrome: a prospective international study. (1985) (473)
Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. (1998) (472)
Long-QT syndrome: from genetics to management. (2012) (465)
Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death. (1984) (460)
Spectrum of ST-T–Wave Patterns and Repolarization Parameters in Congenital Long-QT Syndrome: ECG Findings Identify Genotypes (2000) (455)
Baroreceptor Reflex Control of Heart Rate: A Predictor of Sudden Cardiac Death (1982) (452)
Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. (2011) (448)
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death (2013) (441)
Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome. (1994) (411)
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. (2005) (405)
Long QT syndrome in adults. (2007) (390)
Increased Risk of Arrhythmic Events in Long-QT Syndrome With Mutations in the Pore Region of the Human Ether-a-go-go–Related Gene Potassium Channel (2002) (386)
Left Cardiac Sympathetic Denervation in the Therapy of Congenital Long QT Syndrome: A Worldwide Report (1991) (372)
Prolongation of the QT interval and the sudden infant death syndrome. (1998) (365)
A molecular link between the sudden infant death syndrome and the long-QT syndrome. (2000) (364)
Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. (2004) (345)
The effects of daily exercise on susceptibility to sudden cardiac death. (1984) (341)
The Jervell and Lange-Nielsen Syndrome: Natural History, Molecular Basis, and Clinical Outcome (2006) (340)
Exercise-Induced Increase in Baroreflex Sensitivity Predicts Improved Prognosis After Myocardial Infarction (2002) (338)
Multiple mechanisms of Na+ channel--linked long-QT syndrome. (1996) (336)
Risk stratification for sudden cardiac death: current status and challenges for the future† (2014) (336)
Heart-rate profile during exercise as a predictor of sudden death. (2005) (335)
Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia. (1995) (334)
Effects of unilateral cardiac sympathetic denervation on the ventricular fibrillation threshold. (1976) (331)
Executive Summary: HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes (2013) (321)
Calmodulin Mutations Associated With Recurrent Cardiac Arrest in Infants (2013) (320)
Exercise training confers anticipatory protection from sudden death during acute myocardial ischemia. (1994) (314)
Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and II. (1999) (309)
Evidence for a Cardiac Ion Channel Mutation Underlying Drug‐Induced QT Prolongation and Life‐Threatening Arrhythmias (2000) (308)
Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. (2008) (306)
The 'Sicilian Gambit' - A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms (1991) (306)
Long QT syndrome and pregnancy. (2007) (295)
Nervous activity of afferent cardiac sympathetic fibres with atrial and ventricular endings (1973) (286)
Risk Factors for Aborted Cardiac Arrest and Sudden Cardiac Death in Children With the Congenital Long-QT Syndrome (2008) (285)
Long term vagal stimulation in patients with advanced heart failure First experience in man (2008) (283)
Impact of genetics on the clinical management of channelopathies. (2013) (283)
QTc behavior during exercise and genetic testing for the long-QT syndrome. (2011) (282)
High Efficacy of β-Blockers in Long-QT Syndrome Type 1: Contribution of Noncompliance and QT-Prolonging Drugs to the Occurrence of β-Blocker Treatment “Failures” (2009) (272)
Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals. (2011) (270)
Electrocardiographic Features in Andersen-Tawil Syndrome Patients With KCNJ2 Mutations: Characteristic T-U–Wave Patterns Predict the KCNJ2 Genotype (2005) (268)
Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity (1994) (264)
Gain-of-function mutation S422L in the KCNJ8-encoded cardiac K(ATP) channel Kir6.1 as a pathogenic substrate for J-wave syndromes. (2010) (264)
Modulating effects of age and gender on the clinical course of long QT syndrome by genotype. (2003) (262)
Who Are the Long-QT Syndrome Patients Who Receive an Implantable Cardioverter-Defibrillator and What Happens to Them?: Data From the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry (2010) (262)
Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization (2014) (260)
The Elusive Link Between LQT3 and Brugada Syndrome: The Role of Flecainide Challenge (2000) (260)
NOS1AP Is a Genetic Modifier of the Long-QT Syndrome (2009) (260)
The long QT syndrome: a transatlantic clinical approach to diagnosis and therapy. (2013) (255)
Vagus Nerve Stimulation for the Treatment of Heart Failure: The INOVATE-HF Trial. (2016) (255)
KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome (2005) (250)
The Long QT Syndrome (1997) (250)
Heart rate turbulence-based predictors of fatal and nonfatal cardiac arrest (The Autonomic Tone and Reflexes After Myocardial Infarction substudy). (2002) (250)
Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. LQTS Investigators. (1998) (242)
The congenital long QT syndromes from genotype to phenotype: clinical implications (2006) (235)
Mortality in Patients After a Recent Myocardial Infarction: A Randomized, Placebo-Controlled Trial of Azimilide Using Heart Rate Variability for Risk Stratification (2004) (235)
Cardiac sympathetic innervation and the sudden infant death syndrome. A possible pathogenetic link. (1976) (233)
Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome. (2011) (229)
Vagal Control of the Heart: Experimental Basis and Clinical Implications (1994) (217)
The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. (2008) (216)
Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. (1999) (208)
Predicting the Unpredictable: Drug-Induced QT Prolongation and Torsades de Pointes. (2016) (207)
Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation. (2015) (207)
Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing. (2012) (204)
Guidelines for the interpretation of the neonatal electrocardiogram. A task force of the European Society of Cardiology. (2002) (203)
Gender and the relationship between ventricular repolarization and cardiac cycle length during 24-h Holter recordings. (1997) (201)
Left Stellectomy in the Prevention of Ventricular Fibrillation Caused by Acute Myocardial Ischemia in Conscious Dogs with Anterior Myocardial Infarction (1980) (201)
Comparison of baroreflex sensitivity and heart period variability after myocardial infarction. (1989) (201)
Single cardiac vagal fiber activity, acute myocardial ischemia, and risk for sudden death. (1991) (201)
Phenotypic Variability and Unusual Clinical Severity of Congenital Long-QT Syndrome in a Founder Population (2005) (199)
Cardiac potassium channel dysfunction in sudden infant death syndrome. (2007) (199)
Evaluation of the spatial aspects of T-wave complexity in the long-QT syndrome. (1997) (195)
Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol. (2012) (194)
Quantitative analysis of T wave abnormalities and their prognostic implications in the idiopathic long QT syndrome. (1994) (185)
Efficacy of Permanent Pacing in the Management of High‐Risk Patients With Long QT Syndrome (1991) (184)
Task Force on Sudden Cardiac Death, European Society of Cardiology. (2002) (184)
Ambulatory Electrocardiogram‐Based Tracking of T Wave Alternans in Postmyocardial Infarction Patients to Assess Risk of Cardiac Arrest or Arrhythmic Death (2003) (181)
Prevention of Sudden Cardiac Death After a First Myocardial Infarction by Pharmacologic or Surgical Antiadrenergic Interventions (1992) (181)
Cardiac sympathetic denervation to prevent life-threatening arrhythmias (2014) (180)
Differential response to Na+ channel blockade, beta-adrenergic stimulation, and rapid pacing in a cellular model mimicking the SCN5A and HERG defects present in the long-QT syndrome. (1996) (179)
Vernakalant Hydrochloride for the Rapid Conversion of Atrial Fibrillation After Cardiac Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial (2009) (179)
Age-gender influence on the rate-corrected QT interval and the QT-heart rate relation in families with genotypically characterized long QT syndrome. (1997) (176)
Effects of unilateral stellate ganglion blockade on the arrhythmias associated with coronary occlusion. (1976) (176)
Molecular diagnosis in a child with sudden infant death syndrome (2001) (176)
The long QT syndrome. (1997) (175)
Clinical neurocardiology defining the value of neuroscience‐based cardiovascular therapeutics (2016) (173)
Update of the guidelines on sudden cardiac death of the European Society of Cardiology. (2003) (173)
Cellular dysfunction of LQT5-minK mutants: abnormalities of IKs, IKr and trafficking in long QT syndrome. (1999) (172)
Baroreflex sensitivity and its evolution during the first year after myocardial infarction. (1988) (172)
The autonomic nervous system and sudden death. (1998) (166)
Erratum: Long QT syndrome patients with mutations on the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate: Implications for gene-specific therapy (Circulation (1995) 92 (3381-3386)) (1996) (163)
Congenital long QT syndrome (2008) (163)
The Common Long-QT Syndrome Mutation KCNQ1/A341V Causes Unusually Severe Clinical Manifestations in Patients With Different Ethnic Backgrounds: Toward a Mutation-Specific Risk Stratification (2007) (163)
Neural mechanisms in life-threatening arrhythmias. (1980) (162)
Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation). (2011) (161)
Novel Calmodulin Mutations Associated With Congenital Arrhythmia Susceptibility (2014) (159)
Vagal Stimulation, Through its Nicotinic Action, Limits Infarct Size and the Inflammatory Response to Myocardial Ischemia and Reperfusion (2011) (157)
Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. (2007) (156)
Effect of Stellectomy and Vagotomy on Ventricular Refractoriness in Dogs (1977) (155)
THE ROLE OF THE AUTONOMIC NERVOUS SYSTEM IN SUDDEN CORONARY DEATH * (1982) (155)
Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions (2011) (154)
A recessive variant of the Romano-Ward long-QT syndrome? (1998) (154)
Delayed afterdepolarizations elicited in vivo by left stellate ganglion stimulation. (1988) (154)
Reflex versus tonic vagal activity as a prognostic parameter in patients with sustained ventricular tachycardia or ventricular fibrillation. (1994) (153)
Heart rate variability before and after myocardial infarction in conscious dogs at high and low risk of sudden death. (1990) (150)
Rationale and study design of the increase of vagal tone in heart failure study: INOVATE-HF. (2012) (149)
Protective Effect of Vagal Stimulation on Reperfusion Arrhythmias in Cats (1987) (148)
The idiopathic long QT syndrome: pathogenetic mechanisms and therapy. (1985) (148)
Delayed repolarization (QT or QTU prolongation) and malignant ventricular arrhythmias. (1982) (147)
Stress and sudden death. The case of the long QT syndrome. (1991) (146)
The QT Interval Throughout the First 6 Months of Life: A Prospective Study (1982) (146)
The genetics underlying acquired long QT syndrome: impact for genetic screening. (2016) (145)
Genetic and molecular basis of cardiac arrhythmias; impact on clinical management. Study group on molecular basis of arrhythmias of the working group on arrhythmias of the european society of cardiology. (1999) (145)
Sympathetic–parasympathetic interaction in health and disease: abnormalities and relevance in heart failure (2011) (145)
Genetic and molecular basis of cardiac arrhythmias: impact on clinical management part III. (1999) (145)
Long QT syndrome-associated mutations in intrauterine fetal death. (2013) (142)
Effects of Unilateral Stellectomy upon Cardiac Performance during Exercise in Dogs (1979) (142)
Long-QT Syndrome After Age 40 (2008) (142)
Heart rate variability in patients with ventricular arrhythmias: Effect of antiarrhythmic drugs (1991) (141)
Mortality in the Survival With ORal D-sotalol (SWORD) trial: why did patients die? (1998) (138)
Tonic influence of the sympathetic nervous system on myocardial reactive hyperemia and on coronary blood flow distribution in dogs. (1977) (135)
Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study. (2016) (134)
The European Myocardial Infarct Amiodarone Trial (EMIAT) (1993) (134)
Cardiac Sodium Channel Dysfunction in Sudden Infant Death Syndrome (2007) (129)
How Really Rare Are Rare Diseases?: (2003) (128)
Mapping of body surface potentials in patients with the idiopathic long QT syndrome. (1986) (127)
Sudden cardiac death, genes, and arrhythmogenesis: consideration of new population and mechanistic approaches from a National Heart, Lung, and Blood Institute workshop, Part II. (2001) (126)
Identification of Cadherin 2 (CDH2) Mutations in Arrhythmogenic Right Ventricular Cardiomyopathy (2017) (125)
Cost-effectiveness of neonatal ECG screening for the long QT syndrome. (2006) (124)
Novel characteristics of a misprocessed mutant HERG channel linked to hereditary long QT syndrome. (2000) (120)
A mechanism of cardiac pain suppression by spinal cord stimulation: implications for patients with angina pectoris. (1993) (119)
Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome. (2008) (117)
Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial). (2000) (117)
The effect of antiarrhythmic drugs on life-threatening arrhythmias induced by the interaction between acute myocardial ischemia and sympathetic hyperactivity. (1985) (115)
Are gender differences in QTc present at birth? MISNES Investigators. Multicenter Italian Study on Neonatal Electrocardiography and Sudden Infant Death Syndrome. (1995) (115)
Vagal reflexes and survival during acute myocardial ischemia in conscious dogs with healed myocardial infarction. (1991) (114)
Neural mechanisms in cardiac arrhythmias (1978) (113)
Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study. (2015) (113)
Cardiac Arrhythmias Elicited by Interaction Between Acute Myocardial Ischemia and Sympathetic Hyperactivity: A New Experimental Model for the Study of Antiarrhythmic Drugs (1981) (112)
The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation. (2010) (111)
THE RATIONALE AND THE ROLE OF LEFT STELLECTOMY FOR THE PREVENTION OF MALIGNANT ARRHYTHMIAS (1984) (110)
25th anniversary of the International Long-QT Syndrome Registry: an ongoing quest to uncover the secrets of long-QT syndrome. (2005) (108)
Sudden death and the idiopathic long Q-T syndrome. (1979) (107)
Risk factors for recurrent syncope and subsequent fatal or near-fatal events in children and adolescents with long QT syndrome. (2011) (106)
Favourable effects of heart rate reduction with intravenous administration of ivabradine in patients with advanced heart failure ☆ (2008) (105)
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents. (2012) (105)
CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. (1990) (105)
Unsuspected Echocardiographic Abnormality in the Long QT Syndrome: Diagnostic, Prognostic, and Pathogenetic Implications (1991) (103)
Survival with oral d-sotalol in patients with left ventricular dysfunction after myocardial infarction: rationale, design, and methods (the SWORD trial). (1995) (102)
Electrocardiographic Prediction of Abnormal Genotype in Congenital Long QT Syndrome: Experience in 101 Related Family Members (2001) (99)
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes (2017) (98)
Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction. (1993) (98)
All LQT3 patients need an ICD: true or false? (2009) (96)
Do increases in markers of vagal activity imply protection from sudden death? The case of scopolamine. (1995) (93)
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model (2018) (93)
Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. A study with propranolol, methacholine and oxotremorine in conscious dogs with a healed myocardial infarction. (1993) (92)
Baroreflex sensitivity, but not heart rate variability, is reduced in patients with life-threatening ventricular arrhythmias long after myocardial infarction. (1995) (91)
Prevalent Low-Frequency Oscillation of Heart Rate: Novel Predictor of Mortality After Myocardial Infarction (2004) (91)
Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: the surgical supraclavicular approach to cervicothoracic sympathectomy. (2010) (91)
Two cases of sudden unexpected death in epilepsy in a GEFS+ family with an SCN1A mutation (2008) (90)
High-dose erythropoietin in patients with acute myocardial infarction: a pilot, randomised, placebo-controlled study. (2011) (90)
Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy. (2012) (90)
A Novel Disease Gene for Brugada Syndrome: Sarcolemmal Membrane–Associated Protein Gene Mutations Impair Intracellular Trafficking of hNav1.5 (2012) (89)
Impact of clinical and genetic findings on the management of young patients with Brugada syndrome. (2016) (88)
Dispersion of ventricular repolarization in the long QT syndrome. (1991) (88)
The quest for the mechanisms of the sudden infant death syndrome: doubts and progress. (1987) (87)
New mutations in the KVLQT1 potassium channel that cause long-QT syndrome. (1998) (87)
Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs. (1985) (86)
Genotype-Phenotype Correlation in the Long-QT Syndrome (2001) (86)
FGF12 is a candidate Brugada syndrome locus. (2013) (86)
Evidence of Genetic Heterogeneity in Romano‐Ward Long QT syndrome: Analysis of 23 Families (1994) (85)
Sympathetic modulation of the relation between ventricular repolarization and cycle length. (1991) (84)
Arrhythmogenic Calmodulin Mutations Disrupt Intracellular Cardiomyocyte Ca2+ Regulation by Distinct Mechanisms (2014) (84)
Inherited cardiac arrhythmias (2020) (83)
Effect of dorsal root section on the arrhythmias associated with coronary occlusion. (1976) (83)
Sympathetic-parasympathetic interaction and accentuated antagonism in conscious dogs. (1991) (81)
Early afterdepolarizations induced in vivo by reperfusion of ischemic myocardium. A possible mechanism for reperfusion arrhythmias. (1990) (79)
Rapid Heart Rate Increase at Onset of Exercise Predicts Adverse Cardiac Events in Patients With Coronary Artery Disease (2005) (78)
Cardiac receptor activation and arrhythmogenesis. (1993) (78)
ATRAMI: a mark in the quest for the prognostic value of autonomic markers. Autonomic Tone and Reflexes After Myocardial Infarction. (1998) (78)
Location of Mutation in the KCNQ1 and Phenotypic Presentation of Long QT Syndrome (2003) (77)
Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy Registry. (2019) (77)
[Task Force on Sudden Cardiac Death, European Society of Cardiology. Summary of recommendations]. (2002) (77)
Mechanisms of I(Ks) suppression in LQT1 mutants. (2000) (76)
Risk of death in the long QT syndrome when a sibling has died. (2008) (76)
Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study. (2015) (75)
The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trial. (2004) (73)
Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest. (2019) (73)
Clinical and genetic variables associated with acute arousal and nonarousal-related cardiac events among subjects with long QT syndrome. (2000) (71)
Reflex responses of sympathetic preganglionic neurones initiated by different cardiovascular receptors in spinal animals. (1974) (71)
Patency of infarct-related artery. Effect of restoration of anterograde flow on vagal reflexes. ATRAMI (Automatic Tone and Reflexes After Myocardial Infarction) Investigators. (1996) (70)
Clinical Implications for Affected Parents and Siblings of Probands With Long-QT Syndrome (2001) (70)
Sympathetic--parasympathetic interaction and sudden death. (1990) (69)
Sudden cardiac death, genes, and arrhythmogenesis : consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, part I. (2001) (69)
Identification of a KCNQ1 Polymorphism Acting as a Protective Modifier Against Arrhythmic Risk in Long-QT Syndrome (2013) (68)
Homozygous deletion in KVLQT1 associated with Jervell and Lange-Nielsen syndrome. (1999) (68)
Autonomic control of heart rate and QT interval variability influences arrhythmic risk in long QT syndrome type 1. (2015) (67)
Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation. (2017) (66)
Unexpected Interaction Between β‐Adrenergic Blockade and Heart Rate Variability Before and After Myocardial Infarction: A Longitudinal Study in Dogs at High and Low Risk for Sudden Death (1994) (64)
Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admission. Data from the atrial Fibrillation/flutter Italian REgistry (FIRE). (2004) (63)
Impaired baroreflex sensitivity is correlated with hemodynamic deterioration of sustained ventricular tachycardia. (1997) (62)
The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome. (2006) (61)
Left cardiac sympathetic denervation in the Netherlands for the treatment of inherited arrhythmia syndromes (2014) (59)
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2. (2019) (59)
901–41 Preliminary Mortality Results from the Survival with Oral D-Sotalol (SWORD) Trial (1995) (59)
The idiopathic long Q-T syndrome. (1983) (59)
Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: A systematic review. (2018) (59)
Modifier genes for sudden cardiac death (2018) (57)
Torsade de pointes. Mechanisms and management. (1994) (57)
Prevention of life-threatening arrhythmias by pharmacologic stimulation of the muscarinic receptors with oxotremorine. (1992) (57)
AKAP9 Is a Genetic Modifier of Congenital Long-QT Syndrome Type 1 (2014) (56)
Characterization of SEMA3A-Encoded Semaphorin as a Naturally Occurring Kv4.3 Protein Inhibitor and its Contribution to Brugada Syndrome (2014) (56)
Excessive heart rate increase during mild mental stress in preparation for exercise predicts sudden death in the general population. (2009) (56)
Autonomic Modulation for the Management of Patients with Chronic Heart Failure (2015) (55)
Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome (2020) (55)
Effect of calcium channel block on the wall motion abnormality of the idiopathic long QT syndrome. (1994) (54)
Mexiletine Shortens the QT Interval in Patients With Potassium Channel-Mediated Type 2 Long QT Syndrome. (2019) (54)
CAST and beyond. Implications of the cardiac arrhythmia suppression trials. By the Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. (1990) (53)
Cutting nerves and saving lives. (2009) (53)
Stillbirths, sudden infant deaths, and long-QT syndrome: puzzle or mosaic, the pieces of the Jigsaw are being fitted together. (2004) (53)
Spinal cardiovascular reflexes (1975) (52)
Vagal reflexes following an exercise stress test: a simple clinical tool for gene-specific risk stratification in the long QT syndrome. (2012) (52)
Time- and rate-dependent alterations of the QT interval precede the onset of torsade de pointes in patients with acquired QT prolongation. (1997) (51)
Identification of post acute myocardial infarction patients with potential benefit from prophylactic treatment with amiodarone. A substudy of EMIAT (the European Myocardial Infarct Amiodarone Trial). (1998) (51)
Task Force Report: The legal implications of medical guidelines--a Task Force of the European Society of Cardiology. (1999) (50)
Psychological Stress Preceding Idiopathic Ventricular Fibrillation (2005) (50)
Gene-specific differences in the circadian variation of ventricular repolarization in the long QT syndrome: a key to sudden death during sleep? (2000) (50)
Clinical implications for patients with long QT syndrome who experience a cardiac event during infancy. (2009) (49)
Does pregnancy increase cardiac risk for LQT1 patients with the KCNQ1-A341V mutation? (2006) (49)
Vagal stimulation for heart failure: background and first in-man study. (2009) (48)
Health-Related Quality of Life in Patients With Atrial Fibrillation Treated With Rhythm Control Versus Rate Control: Insights From a Prospective International Registry (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation RECORD-AF) (2014) (48)
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases (2022) (48)
Development of cardiac innervation, ventricular fibrillation, and sudden infant death syndrome. (1992) (48)
Comparison between invasive and non-invasive measurements of baroreflex sensitivity; implications for studies on risk stratification after a myocardial infarction. (2000) (47)
Guidelines for the use of implantable cardioverter defribrillators (1992) (46)
Silent myocardial ischemia in diabetic and nondiabetic patients with coronary artery disease. (2003) (45)
Towards Precision Medicine With Human iPSCs for Cardiac Channelopathies. (2019) (45)
Malignant Perinatal Variant of Long-QT Syndrome Caused by a Profoundly Dysfunctional Cardiac Sodium Channel (2008) (45)
Unexplained cardiac arrest. The need for a prospective registry. (1992) (44)
Torsades de pointes following acute myocardial infarction: evidence for a deadly link with a common genetic variant. (2012) (44)
Multiscale Complexity Analysis of the Cardiac Control Identifies Asymptomatic and Symptomatic Patients in Long QT Syndrome Type 1 (2014) (44)
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents. (1995) (43)
Cardiac response to submaximal exercise in dogs susceptible to sudden cardiac death. (1985) (43)
Cumulative experience of azimilide-associated torsades de pointes ventricular tachycardia in the 19 clinical studies comprising the azimilide database. (2006) (43)
Vagal stimulation for heart failure (2011) (43)
Rationale and objectives for ECG screening in infancy. (2014) (43)
QT Prolongation, Sudden Death, and Sympathetic Imbalance: The Pendulum Swings (2001) (43)
Pathogenesis and Therapy of the Idiopathic Long QT Syndrome (1992) (42)
Management of long QT syndrome (2005) (42)
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome. (2009) (41)
High Efficacy of (cid:1) -Blockers in Long-QT Syndrome Type 1 Contribution of Noncompliance and QT-Prolonging Drugs to the Occurrence of (cid:1) -Blocker Treatment “Failures” (2009) (41)
Of founder populations, long QT syndrome, and destiny. (2009) (41)
Vagal stimulation for heart diseases: from animals to men. An example of translational cardiology (2013) (41)
A wearable remote monitoring system for the identification of subjects with a prolonged QT interval or at risk for drug-induced long QT syndrome. (2018) (41)
Left stellectomy and denervation supersensitivity in conscious dogs. (1982) (41)
Molecular Biology of the Long QT Syndrome: Impact on Management (1997) (41)
Spinal sympathetic reflexes elicited by increases in arterial blood pressure. (1971) (41)
Baroreflex Sensitivity as a Cardiac and Arrhythmia Mortality Risk Stratifier (1997) (41)
The idiopathic long QT syndrome: the need for a prospective registry. (1983) (40)
Vagal stimulation for heart diseases: from animals to men. - An example of translational cardiology.-. (2011) (40)
Genetic testing for long QT syndrome. (2008) (40)
QT interval prolongation and risk of life-threatening arrhythmias during toxoplasmosis prophylaxis with spiramycin in neonates. (1997) (39)
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls (2020) (39)
The Sudden Infant Death Syndrome: Cardiac and Respiratory Mechanisms and Interventions (1988) (39)
Reflex sympathetic changes in aortic diastolic pressure-diameter relationship. (1975) (38)
Another Role for the Sympathetic Nervous System in the Long QT Syndrome? (2001) (37)
Long QT Syndrome: Genotype-Phenotype Correlations (2004) (36)
Newborn ECG screening to prevent sudden cardiac death (2006) (36)
Efficacy of left cardiac sympathetic denervation has an unforeseen side effect: medicolegal complications. (2010) (36)
Can a message from the dead save lives? (2007) (36)
Effect of ventricular fibrillation complicating acute myocardial infarction on long-term prognosis: importance of the site of infarction. (1985) (36)
Vagal activity and ventricular fibrillation (1994) (36)
Do animal models have clinical value? (1998) (36)
Prognostic value of QT interval prolongation in post myocardial infarction patients. (1987) (36)
The search for novel antiarrhythmic strategies (1998) (36)
Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Part 2: ventricular arrhythmias, channelopathies, and implantable defibrillators. (2020) (35)
Cascades or waterfalls, the cataracts of genetic screening are being opened on clinical cardiology. (2010) (35)
The E 1784 K mutation in SCN 5 A is associated with mixed clinical phenotype of type 3 long QT syndrome (2008) (35)
Clinical aspects of ventricular repolarization (1989) (34)
Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: Implications for the clinical management of LQT3 patients (2014) (34)
Long QT Syndrome Modelling with Cardiomyocytes Derived from Human-induced Pluripotent Stem Cells (2018) (33)
The risk of sudden cardiac death in patients with non-ST elevation acute coronary syndrome and prolonged QTc interval: effect of ranolazine. (2013) (33)
The genetics underlying idiopathic ventricular fibrillation: A special role for catecholaminergic polymorphic ventricular tachycardia? (2018) (32)
A comprehensive electrocardiographic, molecular, and echocardiographic study of Brugada syndrome: validation of the 2013 diagnostic criteria. (2014) (32)
Chronic vagal stimulation in patients with congestive heart failure (2009) (32)
Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies (2016) (32)
Role of the Autonomic Nervous System in the Genesis of Early Ischemic Arrhythmias (1985) (31)
Long QT syndrome, a purely electrical disease? Not anymore. (2008) (31)
Determinants of occurrence and survival after sudden cardiac arrest-A European perspective: The ESCAPE-NET project. (2018) (31)
Mutation-specific risk in two genetic forms of type 3 long QT syndrome. (2010) (31)
SCN5A Mutation Type and a Genetic Risk Score Associate Variably With Brugada Syndrome Phenotype in SCN5A Families (2020) (30)
Prediction of unexpected sudden death among healthy dogs by a novel marker of autonomic neural activity. (2008) (30)
Dietary Omega-3 Fatty Acids and Susceptibility to Ventricular Fibrillation: Lack of Protection and a Proarrhythmic Effect (2012) (30)
Nadolol Block of Nav1.5 Does Not Explain Its Efficacy in the Long QT Syndrome (2012) (30)
Hemodynamic Effects of a New Inotropic Compound, PST-2744, in Dogs With Chronic Ischemic Heart Failure (2003) (29)
Efficacy of diltiazem in two experimental feline models of sudden cardiac death. (1986) (29)
Electrocardiographic Screening for Prolonged QT Interval to Reduce Sudden Cardiac Death in Psychiatric Patients: A Cost-Effectiveness Analysis (2015) (28)
SCN5A mutations in 442 neonates and children: genotype–phenotype correlation and identification of higher-risk subgroups (2018) (27)
Sudden cardiac death, founder populations, and mushrooms: what is the link with gold mines and modifier genes? (2011) (27)
Heart rate variability in patients with ventricular arrhythmias: effect of antiarrhythmic drugs. Antiarrhythmic Drug Evaluation Group (ADEG). (1991) (27)
Channelopathies as Causes of Sudden Cardiac Death. (2017) (27)
Ventricular fibrillation induced by the interaction between acute myocardial ischemia and sympathetic hyperactivity: effect of nifedipine. (1988) (27)
Pharmacological and non-pharmacological management of the congenital long QT syndrome: the rationale. (2011) (26)
Idiopathic Long QT Syndrome Exacerbated by Beta‐Adrenergic Blockade and Responsive to Left Cardiac Sympathetic Denervation: Implications Regarding Electrophysiologic Substrate and Adrenergic Modulation (1992) (25)
The early termination of clinical trials: causes, consequences, and control. With special reference to trials in the field of arrhythmias and sudden death. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. (1994) (25)
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2. (2017) (25)
Congenital long QT and short QT syndromes (2009) (25)
Remodelling of cardiac sympathetic re-innervation with thoracic spinal cord stimulation improves left ventricular function in a porcine model of heart failure. (2015) (25)
Mothers with long QT syndrome are at increased risk for fetal death: Findings from a multicenter international study. (2020) (25)
Heterogeneous Regional Endocardial Repolarization is Associated with Increased Risk for Ischemia‐Dependent Ventricular Fibrillation after Myocardial Infarction (2003) (24)
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes (2020) (24)
Effect of reflex vagal activation on frequency of ventricular premature complexes. (1991) (24)
K+ Channel Blockade in the Prevention of Ventricular Fibrillation in Dogs with Acute Ischemia and Enhanced Sympathetic Activity (1995) (24)
Abstract 2860: Efficacy and Safety of Vernakalant Hydrochloride Injection for the Treatment of Atrial Fibrillation After Valvular or Coronary Artery Bypass Surgery (2007) (24)
Significance of QT dispersion in the long QT syndrome. (2000) (24)
Does amiodarone reduce sudden death and cardiac mortality after myocardial infarction? The European Myocardial Infarct Amiodarone Trial (EMIAT). (1994) (24)
The phenotype/genotype relation and the current status of genetic screening in hypertrophic cardiomyopathy, Marfan syndrome, and the long QT syndrome. (1997) (23)
Autonomic Nervous System and Arrhythmias a (1990) (23)
Cardiac sympathetic denervation 100years later: Jonnesco would have never believed it. (2017) (23)
1970-2020: 50 years of research on the long QT syndrome-from almost zero knowledge to precision medicine. (2020) (23)
Vagal stimulation for the treatment of heart failure: a translational success story (2012) (23)
Effects of beta-adrenergic blockade on dispersion of ventricular repolarization in newborn infants with prolonged QT interval. (1997) (22)
Why Did Goethe Marry When He Did? (2008) (22)
Reference values of heart rate variability. (2017) (22)
Tumor necrosis factor-α predicts response to cardiac resynchronization therapy in patients with chronic heart failure. (2014) (21)
Congenital Short QT Syndrome (2010) (21)
An International Multi-Center Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition. (2020) (21)
Exercise Training-Induced Repolarization Abnormalities Masquerading as Congenital Long QT Syndrome (2020) (21)
Genotype-specific QT correction for heart rate and the risk of life-threatening cardiac events in adolescents with congenital long-QT syndrome. (2011) (20)
Genetic Mosaicism in Calmodulinopathy. (2019) (20)
Two‐to‐One AV Block Associated with the Congenital Long QT Syndrome (1999) (20)
Planning with Disjunctive Temporal Constraints (2004) (20)
The rational basis and the clinical value of selective cardiac sympathetic denervation in the prevention of malignant arrhythmias. (1986) (19)
Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility (2022) (19)
Precision Medicine and cardiac channelopathies: when dreams meet reality (2021) (19)
European sudden cardiac arrest network: towards prevention, education, and new effective treatments (2018) (19)
Pro: Newborn ECG screening to prevent sudden cardiac death. (2006) (19)
Practical issues in the management of the long QT syndrome: focus on diagnosis and therapy. (2013) (19)
The idiopathic long QT syndrome: therapeutic management. (1992) (19)
NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis. (2020) (19)
Malignant arrhythmias and acute myocardial ischemia: interaction between flecainide and the autonomic nervous system. (1994) (18)
For neonatal ECG screening there is no reason to relinquish old Bazett’s correction (2018) (18)
QT or Not QT (2000) (18)
Abstract 1778: Electrocardiographic and Genetic Screening for Long QT Syndrome: Results from a Prospective Study on 44,596 Neonates (2007) (18)
Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3' Untranslated Region of KCNQ1? (2016) (18)
Ion channel diseases in children: manifestations and management (2008) (18)
International Triadin Knockout Syndrome Registry: The Clinical Phenotype and Treatment Outcomes of Patients With Triadin Knockout Syndrome (2019) (18)
Baroreceptor reflexes and sudden cardiac death: experimental findings and background. (1992) (18)
The Sicilian Gambit revisited--theory and practice. (1992) (18)
Reflex changes in cardiac vagal efferent nervous acitivty elicited by stimulation of afferent fibres in the cardiac sympathetic nerves. (1972) (18)
New approaches to antiarrhythmic therapy: emerging therapeutic applications of the cell biology of cardiac arrhythmias(1). (2001) (18)
Left Cardiac Sympathetic Denervation for Long QT Syndrome: 50 Years' Experience Provides Guidance for Management. (2021) (17)
[Legal implications of medical guidelines. A Task Force of the European Society of Cardiology]. (2000) (17)
Pertussis toxin-induced ADP ribosylation of inhibitor G proteins alters vagal control of heart rate in vivo. (1993) (17)
Carbon monoxide and lethal arrhythmias in conscious dogs with a healed myocardial infarction. (1989) (17)
The long QT syndrome: new diagnostic and therapeutic approach in the era of molecular biology. (1996) (17)
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death (2013) (17)
Physician Stated Atrial Fibrillation Management in Light of Treatment Guidelines: Data From an International, Observational Prospective Survey (2010) (17)
Effects on atrial repolarization of the interaction between K+ channel blockers and muscarinic receptor stimulation. (1995) (16)
Parasympathetic control of cycle length dependence of endocardial ventricular repolarisation in the intact feline heart during steady state conditions. (1993) (16)
Autonomic Control of the Heart and Its Clinical Impact. A Personal Perspective (2020) (16)
The influence of the autonomic nervous system on sudden cardiac death. (1987) (16)
QT prolongation and ventricular arrhythmias (1992) (15)
Repolarization Abnormalities in the Newborn (2010) (15)
Letter: Role of catecholamines in arrhythmias after acute myocardial infarction. (1975) (15)
THE NEURAL CONTROL OF HEART RATE AND RISK STRATIFICATION AFTER MYOCARDIAL INFARCTION (1999) (15)
Cardiac and Respiratory Mechanisms That Might Be Responsible for Sudden Infant Death Syndrome (1988) (15)
Cardiac Sympathetic Denervation in Channelopathies (2019) (14)
Antiarrhythmic efficacy of penticainide and comparison with disopyramide, flecainide, propafenone and mexiletine by acute oral drug testing. (1987) (14)
Dronedarone in high-risk permanent atrial fibrillation. (2012) (14)
When the risk is sudden death, does quality of life matter? (2016) (14)
An International Multicenter Evaluation of Type 5 Long QT Syndrome (2020) (14)
Mutation location and IKs regulation in the arrhythmic risk of long QT syndrome type 1: the importance of the KCNQ1 S6 region. (2021) (14)
Proarrhythmic proclivity of left-stellate ganglion stimulation in a canine model of drug-induced long-QT syndrome type 1. (2019) (14)
Clinical aspects of life-threatening arrhythmias. (1984) (14)
Rationale and design of a prospective study to assess the effect of left cardiac sympathetic denervation in chronic heart failure. (2017) (14)
Genotype Predicts Outcomes in Fetuses and Neonates With Severe Congenital Long QT Syndrome. (2020) (14)
Mortality due to sudden infant death syndrome in Northern Italy, 1990-2000: a baseline for the assessment of prevention campaigns. (2004) (14)
Activation of cardiac vagal receptors during myocardial ischemia (1971) (14)
Left Cardiac Sympathetic Denervation in Patients with Heart Failure: a New Indication for an Old Intervention? (2014) (13)
Role of the autonomic nervous system in reperfusion arrhythmias. (1988) (13)
Spinal sympathetic reflexes in the cat and the pathogenesis of arterial hypertension. (1975) (13)
Myocardial infarction and baroreflex sensitivity. Clinical studies. (1992) (13)
Long QT syndrome, artificial intelligence, and common sense. (2021) (13)
Low-Pass Filtering Approach via Empirical Mode Decomposition Improves Short-Scale Entropy-Based Complexity Estimation of QT Interval Variability in Long QT Syndrome Type 1 Patients (2014) (13)
Erratum: Task force on sudden cardiac death of the European society of cardiology (European Heart Journal (2001) 22 (1374-1450)) (2002) (12)
Management of survivors of cardiac arrest — the importance of genetic investigation (2016) (12)
Antifibrillatory efficacy of ersentilide, a novel beta-adrenergic and Ikr blocker, in conscious dogs with a healed myocardial infarction. (1998) (12)
Cardiac arrest and Brugada syndrome: Is drug-induced type 1 ECG pattern always a marker of low risk? (2017) (12)
Analysis of HLA and disease susceptibility: chromosome 6 genes and sex influence long-QT phenotype. (1994) (12)
Sudden cardiac death. Nonpharmacologic interventions. (1987) (12)
There are 100 ways by which the sympathetic nervous system can trigger life-threatening arrhythmias. (2020) (12)
Lack of correlation between occlusion and reperfusion arrhythmias in the cat. (1985) (11)
Empiric Quinidine for Asymptomatic Brugada Syndrome—Preliminary Results of an International Registry (2012) (11)
Muscarinic Effects on Action Potential Duration and its Rate Dependence in Canine Purkinje Fibers (1996) (10)
Left cardiac sympathetic denervation in long QT syndrome patients. (1995) (10)
Vagal Stimulation and Prevention of Sudden Death (2005) (10)
The European Myocardial Infarct Amiodarone Trial (EMIAT). EMIAT Investigators. (1993) (10)
An International Multicenter Cohort Study on β-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular Tachycardia (2021) (10)
Clinical problem-solving. QT or not QT? (2000) (10)
Cadherin 2-Related Arrhythmogenic Cardiomyopathy (2021) (10)
Sudden infant death syndrome and cardiac channelopathies: from mechanisms to prevention of avoidable tragedies (2011) (10)
An experimental approach to the problem of post-infarction angina and sudden cardiac death. (1986) (10)
Continued misuse of orphan drug legislation: a life-threatening risk for mexiletine. (2020) (10)
Effect of Calcium Channel Block on the Wall Motion Abnormalit of the Idiopathic Long QT Syndrome (2005) (10)
Infanticide vs. inherited cardiac arrhythmias (2020) (10)
Corrigendum to: ‘Recommendations for interpretation of 12-lead electrocardiogram in the athlete’ [Eur Heart J 2010;31:243–259] (2010) (10)
Clinical applicability of molecular biology: the case of the long QT syndrome (2000) (10)
[Idiopathic ventricular fibrillation: from a collection of clinical cases to a prospective evaluation. The U-CARE Steering Committee. Unexplained Cardiac Arrest Registry of Europe]. (1995) (9)
Experimental evidence for beta adrenergic blocking properties of propafenone and for their potential clinical relevance. (1993) (9)
Cardiac arrhythmias of genetic origin are important contributors to sudden infant death syndrome. (2007) (9)
Genetics of Peripartum Cardiomyopathy: Current Knowledge, Future Directions and Clinical Implications (2021) (9)
Physical Inactivity Is a Risk Factor for Primary Ventricular Fibrillation. (2019) (9)
AI-enabled wargaming in the military decision making process (2020) (9)
Abnormal myocardial expression of SAP97 is associated with arrhythmogenic risk. (2020) (9)
Sudden cardiac death in young competitive athletes. (2012) (9)
A molecular basis for the therapy of the long QT syndrome. (1996) (8)
Efficacy and safety of flecainide in low-risk patients with chronic ventricular arrhythmias: a two-year follow-up. (1989) (8)
Can genetics predict risk for sudden cardiac death? The relentless search for the Holy Grail (2018) (8)
Alpha1‐Adrenergic Blockade and Sudden Cardiac Death (1994) (8)
Interventions changing heart rate variability after acute myocardial infarction (1995) (8)
The unstoppable attraction for induced pluripotent stem cells: are they the magic bullet for modeling inherited arrhythmogenic diseases? (2012) (8)
The long QT syndrome: a clinical counterpart of hERG mutations. (2005) (8)
New Mutations in the KVLQT 1 Potassium Channel That Cause Long-QT Syndrome (1998) (8)
Response by Crotti et al to Letter Regarding Article, "Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3' Untranslated Region of KCNQ1?" (2016) (8)
[Sudden death after myocardial infarction. Prediction based on the baroreceptor reflex]. (1990) (8)
The Role of the Sympathetic Nervous System in the Long QT Syndrome: The Long Road from Pathophysiology to Therapy (2012) (8)
The prognostic value of baroreflex sensitivity and heart rate variability after myocardial infarction The ATRAMI study (1996) (8)
Electronic gadgets and their health-related claims. (2018) (8)
Patient-Specific Induced Pluripotent Stem Cell-Based Disease Model for Pathogenesis Studies and Clinical Pharmacotherapy. (2017) (8)
Neonatal ECG screening: opinions and facts. (2015) (7)
Multiple comparison of several antiarrhythmic agents by acute oral drug testing in patients with chronic ventricular arrhythmias. (1988) (7)
How reliable are clinical trials? The importance of the criteria for early termination. (1995) (7)
Managing Complex Scheduling Problems with Dynamic and Hybrid Constraints (2007) (7)
Cardiac arrhythmias in infancy: prevalence, significance and need for treatment. (1984) (7)
Gene symbol: KCNH2. Disease: Long QT syndrome. (2008) (7)
Diverse electrophysiologic effects of propafenone and flecainide in canine Purkinje fibers: implications for antiarrhythmic drug classification. (1994) (7)
Vagal Stimulation in Heart Failure: An Anti-inflammatory Intervention? (2016) (7)
Effects of the potassium channel blocking agent ambasilide on ventricular arrhythmias induced by acute myocardial ischemia and sympathetic activation. (1995) (7)
[Long QT syndrome and Brugada syndrome: 2 aspects of the same disease?]. (2001) (6)
Variable phenotype of long QT syndrome patients with the same genetic defect (1998) (6)
Heart Rate Recovery After Exercise Is Associated With Arrhythmic Events in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia (2020) (6)
Prolonged Repolarization and Sudden Infant Death Syndrome (2003) (6)
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1. (2018) (6)
After Jena: Goethe's Elective Affinities and the End of the Old Regime (2010) (6)
The Myth of QT Shortening by Weight Loss and Physical Training in Obese Subjects With Coronary Heart Disease (2011) (6)
MY APPROACH to the long QT syndrome (LQTS). (2015) (6)
The Role of the Cardiac Sodium Channel in Perinatal Early Infant Mortality (2014) (6)
ROLE OF CATECHOLAMINES IN ARRHYTHMIAS AFTER ACUTE MYOCARDIAL INFARCTION (1975) (6)
Electrophysiologic mechanisms involved in the development of torsades de pointes (1991) (6)
A multicenter, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Preliminary report (1990) (6)
Refined multiscale entropy analysis of heart period and QT interval variabilities in long QT syndrome type-1 patients (2013) (6)
Sudden death by stress: how far under the nerves should we dig to find out why LQT1 patients die? (2014) (6)
Risk factors for primary ventricular fibrillation during a first myocardial infarction: Clinical findings from PREDESTINATION (PRimary vEntricular fibrillation and suDden dEath during firST myocardIal iNfArcTION). (2019) (6)
When prescribing drugs, do medical doctors and healthcare professionals realize that their patient has the long QT syndrome? (2019) (5)
Two Approaches to Semi-Dynamic Disjunctive Temporal Problems (2005) (5)
An experimental approach to the choice of antiarrhythmic therapy. (1986) (5)
Rapid Recovery of Baroreceptor Reflexes in Acute Myocardial Infarction is a Marker of Effective Tissue Reperfusion (2014) (5)
Drug-induced long QT syndrome and exome sequencing: Chinese shadows link past and future. (2014) (5)
Autonomic modulation for chronic heart failure: a new kid on the block? (2012) (5)
The Sicilian Gambit: a response to Drs Colatsky and Harrison. (1992) (5)
Implantable defibrillators in primary prevention of genetic arrhythmias. A shocking choice? (2022) (5)
Evolving concepts for the Long QT Syndrome. (2017) (5)
Tocainide and mortality after myocardial infarction: a prospective study in conscious dogs. (1990) (5)
AKAP 9 is a Genetic Modifier of Congenital Long-QT Syndrome Type 1 Running title (2014) (5)
Long QT genotype can be identified by ECG phenotype (1998) (5)
Introduction to the arrhythmogenic disorders of genetic origin series. (2012) (5)
Postnatal development of cardiac innervation and susceptibility to malignant arrhythmias in the dog. (1990) (5)
Regional Lack of Consistency in the Management of Atrial Fibrillation (from the RECORD-AF Trial). (2017) (5)
Report from the Task Force of the European Society of Cardiology for the interpretation of the neonatal electrocardiogram (2002) (4)
Carbon monoxide and lethal arrhythmias. (1990) (4)
Long and Short QT Syndromes (2018) (4)
A Refined Multiscale Self-Entropy Approach for the Assessment of Cardiac Control Complexity: Application to Long QT Syndrome Type 1 Patients (2015) (4)
Use of hiPSC-Derived Cardiomyocytes to Rule Out Proarrhythmic Effects of Drugs: The Case of Hydroxychloroquine in COVID-19 (2021) (4)
Precision Versus Traditional Medicine-Clinical Questions Trigger Progress in Basic Science. (2019) (4)
ThelongQT syndrome: a prospective international (1985) (4)
Demonstration of a different sensitivity to epinephrine in isolated and in vivo hearts. (1988) (4)
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi006-A from a patient affected by an autosomal recessive form of long QT syndrome type 1. (2019) (4)
Common KCNH2 Polymorphism (K897T) as a genetic modifier of congenital long QT syndrome (2005) (4)
Continental Europe triumph in golf competition (2002) (4)
Vox clamantis in deserto. We spoke but nobody was listening: echocardiography can help risk stratification of the long-QT syndrome. (2015) (4)
Stress, the autonomic nervous system, and sudden death (2021) (4)
Unilateral stellectomy and dysrhythmias. (1978) (4)
Gene-specific lethality of arrhythmic events in the long QT syndrome? A message from the International Registry. (1999) (4)
Hemodynamic response to exercise following oral administration of amiodarone (1983) (4)
Abstract 2412: Chronic Vagus Nerve Stimulation in Patients with Chronic Heart Failure is Feasible and Appears Beneficial (2008) (4)
AB1-5: Gain of function KCNQ1 mutation associated with sudden infant death syndrome (2006) (4)
The Ideological Antecedents of the First-Series Renminbi Worker-and-Peasant Banknote or What Mao Tse-tung May Have Owed to Dziga Vertov (2014) (4)
Out‐of‐hospital cardiac arrest and differential risk of cardiac and non‐cardiac QT‐prolonging drugs in 37 000 cases (2021) (4)
From exercise training to sudden death prevention via adrenergic receptors. (2007) (4)
Counterfeit drugs: A plot worthy of John le Carrè. (2017) (3)
How many cases of sudden infant death syndrome are due to the long QT syndrome (2005) (3)
Genetic evidence links long QT syndrome and stillbirth (2010) (3)
Mortality in the Survival With ORal D-Sotalol (SWORD) Trial: Why Did Patients Die? 1 1 This work was (1996) (3)
Innovation in cardiovascular disease in Europe with focus on arrhythmias: current status, opportunities, roadblocks, and the role of multiple stakeholders. (2018) (3)
Catecholamine-Dependent Cardiac Arrhythmias: Mechanisms and Implications (1989) (3)
Abstract 13371: CALM2 Mutations Associated With Atypical Juvenile Long QT Syndrome (2013) (3)
Activity of cardiac receptors during experimental reduction in coronary flow (1972) (3)
PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis (2013) (3)
Sudden Infant Death Syndrome and Genetics: Don't Throw Out the Infant With the Dirty Water. (2018) (3)
Monday, 27 August 2012 (2012) (3)
Cardiac sympathetic denervation in the prevention of genetically mediated life-threatening ventricular arrhythmias (2022) (3)
Cardiac Pain, Sympathetic Afferents, and Life‐Threatening Arrhythmias (1991) (3)
Harmonization of the Definition of Sudden Cardiac Death in Longitudinal Cohorts of the ESCAPE-NET Consortium. (2021) (3)
Abstract 2249: Overlap Between LQT3 and Brugada Syndrome: Clinical Features in a Common Mutation and Underlying Biophysical Mechanisms (2007) (3)
Phenotypic characterization of Timothy syndrome - a complex cardiac and multisystem disorder (2005) (3)
Estimating the Posttest Probability of Long QT Syndrome Diagnosis for Rare KCNH2 Variants (2021) (3)
KCNH2-K897T Polymorphism Increases the Risk of Life-Threatening Arrhythmias Following Acute Myocardial Infarction (2010) (3)
Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population. (2019) (3)
Effects of gender on the dynamic relation between ventricular repolarization and heart rate (1996) (3)
Gene symbol: KCNH2. (2007) (3)
CO 2 The impact of clinical and genetic findings on the management of young Brugada syndrome patients (2015) (3)
Gene symbol: KCNQ1. (2007) (3)
The familial long QT syndrome study: Prospective cardiac and genetic investigation involving 292 families (1990) (3)
16Ethnicity and phenotype in the SCN5A E1784K mutation (2014) (3)
Vagal reflexes elicited by acute myocardial ischemia during exercise in dogs with a healed myocardial infarction (1984) (2)
Management of Congenital Long-QT Syndrome: Commentary From the Experts (2021) (2)
Long QT Syndrome and Sport: My Views (2018) (2)
Novel human pathological mutations. Gene symbol: SCN5A. Disease: Brugada Syndrome. (2009) (2)
Response to Letters Regarding Article, "Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation". (2016) (2)
Dispersion of repolarization and the genotype of long QT syndrome (1996) (2)
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation. (2019) (2)
Atenolol is not effective in reducing ventricular arrhythmia severity on exercise stress test in patients with catecholaminergic polymorphic ventricular tachycardia (2020) (2)
Pathophysiological mechanisms of sudden infant death syndrome (1992) (2)
Adrenergic Arrhythmogenesis and the Long Q-T Syndrome (1989) (2)
120 Heart rate turbulence slope triggered by atrial premature complexes correlates with phenylephrine baroreflex sensitivity in the ATRAMI study (2005) (2)
Cost concerns for implantable cardioverter defibrillators implant in post myocardial infarction patients: The value of autonomic markers (2005) (2)
Cardiac sympathetic innervation and the prevention of sudden death. (1990) (2)
Combined Sodium and Calcium Channel Blockade in Prevention of Lethal Arrhythmias (2003) (2)
Principal component analysis of repolarization: A novel index of complexity of ventricular repolarization in the long QT syndrome (1996) (2)
Remote Monitoring of the QT Interval and Emerging Indications for Arrhythmia Prevention. (2021) (2)
P297Cardiac sympathetic denervation: evolving technique, expanding indications (2018) (2)
The ATRAMI Prospective Study: Implications for Risk Stratification after Myocardial Infarction (1998) (2)
The influence of beta-blockers on QT interval in patients with long QT syndrome (1996) (2)
Corrigendum: Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies (2016) (2)
Counting Heart Beats: (2003) (2)
Abstract 14840: International Calmodulinopathy Registry (ICaMR) (2016) (2)
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene. (2019) (2)
Novel Calmodulin (CALM2) Mutations Associated with Congenital Arrhythmia Susceptibility (2)
Reflex activity of single preganglionic sympathetic fibres during coronary occlusion (1969) (2)
Cardiac sympathetic denervation via a transtracheal approach: It's a long way to Tipperary. (2019) (2)
Red Bull®: Red flag or red herring? (2017) (2)
Alpha 1-adrenergic blockade and sudden cardiac death. (1994) (2)
Evolution in Managing Long QT Syndrome: From Registries to Centers of Excellence. (2017) (2)
Natural history and genetic aspects of the Jervell and Lange-Nielsen syndrome. (2001) (2)
Tonic afferent sympathetic activity from the heart (1972) (2)
Pregnancy Increase Cardiac Risk for QT 1 Patients With the KCNQ 1-A 341 V Mutation ? (2006) (2)
Abstract 2927: Long QT Syndrome as a Cause of Stillbirths (2007) (2)
Abstract 17001: Long-Term Benefits of Vagal Nerve Stimulation Therapy in Heart Failure (2012) (2)
Non-Pharmacologic Manipulation of the Autonomic Nervous System in Human for the Prevention of Life-Threatening Arrhythmias (2009) (2)
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene. (2018) (2)
NEAR-MISS SUDDEN INFANT DEATH (1976) (2)
The Answers to Questions Surrounding Left Cardiac Sympathetic Denervation are in the Library, Covered by Dust. (2020) (1)
The Role of Left Stellectomy in the Prevention of Lethal Arrhythmias (1988) (1)
Abstract 4634: Profile of Patients According to Chosen Therapeutic Strategy in the RecordAF Global Registry on Atrial Fibrillation Management (2008) (1)
A cardiac murmur depending on the Wolff-Parkinson-White syndrome. (1972) (1)
24 – Neural and Spinal Stimulation (2017) (1)
Baroreceptive reflexes and cardiac electrical instability in patients with a myocardial infarction (1985) (1)
Correction: Electrocardiographic Screening for Prolonged QT Interval to Reduce Sudden Cardiac Death in Psychiatric Patients: A Cost-Effectiveness Analysis (2015) (1)
Cardiac Repolarization and Stem Cells: An Emerging Path Toward Precision Medicine (2019) (1)
Baroreflex Sensitivity (1995) (1)
Arrhythmic Risk in Long-QT Syndrome Polymorphism Acting as a Protective Modifier Against KCNQ 1 Identification of a (2013) (1)
Gene symbol: SCN5A. Disease: Brugada syndrome. (2008) (1)
Reply to the Editor--Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients. (2014) (1)
Time, frequency and information domain analysis of heart period and QT variability in asymptomatic long QT syndrome type 2 patients (2015) (1)
Genetic testing for the long QT syndrome: who and why? Insights for clinical management (2012) (1)
Blocking nerves and saving lives: Left stellate ganglion block for electrical storms. (2022) (1)
NOS1AP Is a Genetic Modifier of Congenital Long-QT Syndrome (2009) (1)
Abstract 4048: Chronic Vagus Nerve Stimulation in Patients With Heart Failure: Potential Predictors of Success (2009) (1)
The role of neonatal electrocardiography in the early identification of genetic arrhythmogenic disorders and congenital cardiovascular diseases: prospective data from 25865 infants (2005) (1)
The Void at the Center of Things: Figures of Identity in Michael Haneke's Glaciation Trilogy (2010) (1)
[Clinical conditions associated with abnormal QT interval: clinical implications]. (2013) (1)
[Prevention of sudden death in myocardial infarct: do experimental results help to understand the clinical reality? The case of the clinical trial SWORD (Survival With ORal D-sotalol)]. (1996) (1)
Neural Factors in Sudden Death (1984) (1)
Amiodarone in the Prevention of Malignant Arrhythmias Due to Myocardial Ischaemia and Sympathetic Hyperactivity (1985) (1)
ECG repolarization parameters in LQTS family members with borderline QTC duration and cardiac events (1998) (1)
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation. (2019) (1)
Alberto Zanchetti (27 July 1926). (2018) (1)
Abstract 16441: Novel Calmodulin Mutations Cause Congenital Long QT Syndrome and Affect Calcium Current in Human Cardiomyocytes (2015) (1)
Pertussis toxin alters vagal control of heart rate in conscious dogs (1989) (1)
746-1 Antifibrillatory Effect of HE-93, a New K+Channel and β Adrenergic Blocker in Conscious Dogs with a Healed Myocardial Infarction (1995) (1)
Genome-Wide Association Analysis Identifies 3 Common Variants Predisposing to Brugada Syndrome, a Rare Disease with High Risk of Sudden Cardiac Death (2013) (1)
Electrocardiographic screening for drug-induced long qt to reduce sudden cardiac death in Psychiatric patients: a cost-effectiveness analysis (2015) (1)
Continuous Bayesian Variant Interpretation Accounts for Incomplete Penetrance among Mendelian Cardiac Channelopathies (2022) (1)
Founder populations with channelopathies and church records reveal all sorts of interesting secrets: Some are scientifically relevant. (2017) (1)
What Have We Learned from the SWORD Trial? Can Potassium Channel Blockers Reduce Sudden Cardiac Death? (1996) (1)
Arrhythmias depending upon a cardio cardiac sympathetic reflex (1975) (1)
Influence of the Autonomic Nervous System on the Action of Antiarrhythmic Drugs (1995) (1)
[Sudden infant death syndrome in Italy. A multidisciplinary approach]. (1983) (1)
Cardiac Innervation and Sudden Death: New Strategies for Prevention (1989) (1)
Reply to the Editor--Detection of long QT syndrome in the community. (2015) (1)
Prevalence and Phenotypic Correlations of Calmodulinopathy-Causative CALM1-3 Variants Detected in a Multi-Center Molecular Autopsy Cohort of Sudden Unexplained Death Victims. (2020) (1)
Cardiac Channelopathies and Sudden Infant Death Syndrome (2013) (1)
Paroxysmal Atrial Fibrillation and the Autonomic Nervous System (1992) (1)
Fear of Sudden Death During Sport Activity and the Long QT Syndrome (2021) (1)
Long QT syndrome with cardiac arrest and transient short QT due to a novel KCNH2 mutation causing both loss and gain of function (2005) (1)
Constraint Optimization Literature Review (2015) (1)
[Effects of vagal stimulation in conscious dogs with previous myocardial infarct]. (1988) (1)
(SWORD) Trial: Why Did Patients Die? (1996) (1)
Long QT syndrome patients genetically linked to defective genes on chromosomes 11, 7 and 3 present differential response to changes in heart rate (1996) (1)
Long QT syndrome: from genetic basis to treatment (2011) (1)
Aby Warburg and Cinema, Revisited (2020) (1)
93 – Long and Short QT Syndromes (2014) (1)
Eduard's Egotism: Historical Notes on Goethe's Elective Affinities (2001) (1)
Clinical update The long QT syndrome : a transatlantic clinical approach to diagnosis and therapy (2013) (1)
Task Force 5 : Nonpharmacologic approaches to the treatment of hypertension (2005) (1)
Corrigendum: Cellular dysfunction of LQT5-minK mutants: Abnormalities of IKs, IKr and trafficking in long QT syndrome (Human Molecular Genetics (1999) 8 (1499-1507)) (1999) (1)
Antidepressants, QT interval and cardiovascular risk. Justified concerns? (2012) (1)
Symbolic analysis of heart period and QT interval variabilities in LQT1 patients (2014) (1)
Gene symbol: SCN5A. (2007) (1)
Genotype-Phenotype Correlation in Induced Pluripotent Stem Cell (iPSC)Derived Cardiomyocytes Carrying Calmodulin Mutations (2014) (1)
Molecular genetic testing in athletes: Why and when a position statement from the Italian society of sports cardiology. (2022) (1)
[Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method]. (1985) (1)
Can we Modulate the Autonomic Nervous System to Improve the Life of Patients with Heart Failure? The Case of Vagal Stimulation. (2014) (1)
Autonomic mechanisms in ventricular fibrillation (2005) (1)
[Infant mortality and sudden crib death in Lombardy]. (2004) (1)
[Activity of preganglionic sympathetic single fibers during experimental coronary occlusion]. (1968) (1)
[Sympathetic reflex induced by experimental coronary occlusion]. (1969) (1)
Multiscale Complexity Analysis of Short QT Interval Variability Series Stratifies the Arrhythmic Risk of Long QT Syndrome Type 1 Patients (2018) (1)
Modulation of the Electrical Restitution of Canine Purkinje Fibers by Local Anesthetic Drugs: A Study with Flecainide and Propafenone (1994) (1)
An impedance-guided intra arterial catheter (2013) (1)
‘ Left ventricular mechanical dispersion by tissue Doppler imaging : a novel approach for identifying high risk individuals with long QT syndrome ’ † (2009) (1)
Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes Carrying CALM1-F142l Mutation Recapitulate LQTS Phenotype in Vitro (2016) (1)
Evidence for a spinal sympathetic regulation of cardiovascular functions (1970) (1)
Identification of a Romano-Ward founder effect in South Africa (2005) (0)
Chronic Vagus Nerve Stimulation – Effects on Heart Rate and Heart Rate Variability Corroborate Clinical Improvement (2009) (0)
Abstract 3393: The Common LQT1 Mutation KCNQ1/A341V Predicts High Risk of Cardiac Events in Different Ethnic Backgrounds (2006) (0)
Mexiletine in the Prevention of Sudden Cardiac Death: Experimental Evaluation and Clinical Implications (1986) (0)
Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility (2022) (0)
HLA-C KIR LIGANDS and HLA-G INS/DEL 14BP dimorphism in stillbirth (2012) (0)
β-adrenergic blockade and heart rate [6] (1995) (0)
Use of baroreceptor reflex sensitivity in the prediction of risk after myocardial infarction (1996) (0)
Monogenic and oligogenic cardiovascular diseases: genetics of arrhythmias—catecholaminergic polymorphic ventricular tachycardia (2018) (0)
Commentary Clinical applicability of molecular biology: the case of the long QT syndrome (2000) (0)
Review Article Congenital Short QT Syndrome (2010) (0)
Chapter 34 – The Long QT Syndrome (2005) (0)
Gene symbol: KCNH2. Disease: Long QT syndrome. (2008) (0)
Biventricular Arrhythmogenic Cardiomyopathy: a paradigmatic case (2015) (0)
Relationship between action potential duration and cycle length in patients with the long QT syndrome. Observations on sinus node function and AV conduction (1991) (0)
FUNCTIONAL EFFECTS OF SCN5A CHANNEL MUTATIONS AND THE RISK OF LIFE-THREATENING EVENTS IN TYPE 3 LONG QT SYNDROME (2016) (0)
290 The KCNQ1 rs2074238 polymorphism is a genetic modifier of cardiac risk in long QT syndrome (2012) (0)
[Changes of a reflex nature in the cardiac sympathetic activity induced with increases of arterial pressure in spinal animals]. (1970) (0)
Long QT Syndrome: from Molecular Biology to Clinical Management (1998) (0)
258 - The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by long QT syndrome type 2 (2017) (0)
AB1-6: Screening for known mutations in LQTS: A novel way to fast and low cost genotyping? (2006) (0)
Running title: Genome-wide association study in long QT syndrome (2020) (0)
0842 International Session Low Baroreceptor Reflex Sensitivity is Associated with Worse Hemodynamic Tolerability of Sustained Ventricular Tachycardia (1996) (0)
Abstract 17782: Both Common and Rare SCN10A Variants Associated with Brugada Syndrome Displayed an Increase in Late Nav1.8 Sodium Currents in ND 7/23 cells (2014) (0)
Idiopathic long QT syndrome: Genetic, epidemiologic and cardiac studies (1988) (0)
Abnormal heart rate control in SCN5A‐[Delta]KPQ Mice (2012) (0)
B-PO04-026 NON-SELECTIVE VERSUS Β1-SELECTIVE BETA-BLOCKERS IN THE TREATMENT OF SYMPTOMATIC CHILDREN WITH CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA (2021) (0)
The Case of the Long QT Syndrome (2005) (0)
Frequency Domain Heart Period and QT Interval Variability Markers Are Linked to Arrhythmic Risk in Long QT Syndrome Type 2 (2020) (0)
ST-RESOLUTION FOLLOWING PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN ACUTE MYOCARDIAL INFARCTION IS ASSOCIATED WITH EARLY RECOVERY OF VAGAL REFLEXES. (2010) (0)
BETA -ADRENERGIC BLOCKADE AND HEART RATE. AUTHORS' REPLY (1995) (0)
AB28-1: Individual autonomic profile contributes to the risk for life-threatening arrhythmias among KCNQ1-A341V mutation carriers (2006) (0)
Aborted cardiac arrest and cardiac death in the long QT syndrome patients with documented Torsades de Pointes (1998) (0)
In Memoriam: Alberto Zanchetti (Parma July 27, 1926 – Milan March 24, 2018) (2018) (0)
The Search for Modifiers Genes in Long QT Syndrome and Its Impact on Management (2011) (0)
Clinical Aspects of Life Threatening Arrhythmias, Volume 427. (1984) (0)
Gene symbol: SCN5A. (2007) (0)
[Neonatal electrocardiography and the sudden infant death syndrome (SIDS)]. (1977) (0)
Sympathetic Nervous System and Malignant Arrhythmias: Evidence for Further Links (1989) (0)
[The sympathetic nervous system and sudden cardiac death]. (1981) (0)
Letter concerning the editorial by Giustetto et al. Int J Cardiol 2018;254:170-171. (2018) (0)
XIVth Congress of the European Society of Cardiology in Barcelona: Foreword (1992) (0)
P1-21: Qtc shortening secondary to decreased heart rate contributes to the antiarrhythmic efficacy of beta-blockers in LQT1 patients (2006) (0)
Riskstratificationforsuddencardiacdeath:current status and challenges for the future † (2014) (0)
Compendium of Published Texts in Pacing and Electrophysiology (2004) (0)
Long-QT syndrome type 1 (LQT1) : neural control of heart rate is a modifier of risk : abstract (2008) (0)
QT Interval, Total Calcium Blood Levels, and SIDS (1988) (0)
Introduction IJC Special Issue on Sudden Cardiac Death. (2017) (0)
In Memoriam: Alberto Zanchetti (Parma 27 July 1926–Milan 24 March 2018) (2018) (0)
A Systems Biology Approach to Decipher Genetic Variants in a Canine Model of Sudden Cardiac Death (2019) (0)
Sudden Infant Death Syndrome and Genetics (0)
The hemodynamic response to exercise in dogs susceptible to sudden cardiac death (1985) (0)
Beyond LQT3 and brugada syndrome: The search for the overlapping phenotypes (2001) (0)
Brief Communications Exercise Training Confers Anticipatory Protection From Sudden Death During Acute Myocardial Ischemia (2005) (0)
1100 Circ Arrhythm Electrophysiol December 2012 Results Mutational Analysis of SLMAP (0)
Comparative Evaluation of Antiarrhythmic Therapy (2012) (0)
PART III. NEW TOOLS FOR DEFENSE DECISIONMAKING (2003) (0)
A cardiuc murmur dupending on the Wotff-Parkinson-White syndrome (1972) (0)
Resounding victory in golf of the Continental Europe Team of Cardiology. (2022) (0)
[Cardio-cardiac sympathico-vagal reflex]. (1972) (0)
Abstract 9687: Vagal Reflexes as a Simple Clinical Tool to Stratify Risk Among LQT1 Patients (2011) (0)
Gene symbol: KCNQ1. Disease: Long QT syndrome. (2008) (0)
[From clinical medicine to electrophysiology. The case of the long QT syndrome]. (1987) (0)
Pathophysiology and Prevention of Atrial Fibrillation Current Perspective (2001) (0)
Cardiovascular risk in SIDS (1991) (0)
Sudden Cardiac Death in Infancy: Focus on Prolonged Repolarization (2008) (0)
Dynamic relation between ventricular repolarization and heart rate in the long QT syndrome (1996) (0)
Bongani Mayosi, 1967-2018. (2018) (0)
Cardiac arrhythmias and arrhythmogenic conditions (2010) (0)
The state of therapy in the idiopathic long QT syndrome (1982) (0)
Rationale and study design of the IN crease O f V agal T on E in H eart F ailure study : INOVATE-HF (2012) (0)
Filtering approach based on empirical mode decomposition improves the assessment of short scale complexity in long QT syndrome type 1 population (2014) (0)
Is Careful Assessment of Rare Variants in the RYR2 Gene Piercing the Guidelines' Strong Armor? (2018) (0)
163 Genetic Modifiers in Carriers of the SCN5A E1784K Mutation with Variable Phenotypic Expression - Long QT3 / Brugada Syndrome Overlap Disease (2014) (0)
663 OCCURRENCE OF VENTRICULAR AND SUPRAVENTRICULAR ARRHYTHMIAS IN BRUGADA SYNDROME: RESULTS OF A TERTIARY REFERRAL CENTER EXPERIENCE (2022) (0)
Gene Therapy for Long QT Syndrome: Fact or Fiction? (2000) (0)
Health-Related Quality of Life in Patients With Atrial Fibrillation Treated With Rhythm Control Versus Rate Control (2014) (0)
Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility (2022) (0)
[Neural mechanisms of sudden death]. (1984) (0)
Inherited Cardiac Arrhythmia Role of Potassium Channels (2011) (0)
Pathophysiological rationale for cardiac vagal denervation in the treatment of atrial fibrillation (2004) (0)
Effects of ambasilide, a new K+ channel blocker on ventricular arrhythmias induced by acute myocardial ischemia and sympathetic activation (1993) (0)
Abstract 16150: Desmoplakin Missense vs Non-missense Mutations: Genotype-phenotype Correlations in Arrhythmogenic Right Ventricular Cardiomyopathy (2016) (0)
Abstract 21572: Spectrum and Prevalence of Mutations Involving the Known Brugada Syndrome-Susceptibility Genes in a Large Cohort of Unrelated Patients with Clinically Diagnosed Brugada Syndrome (2010) (0)
ICD for the Long QT Syndrome: Which Indications, Complications, and Results? (2006) (0)
WHO WAS ANDRÉ JOLLES?1 BORN IN DEN HELDER IN 1874; RAISED IN AMSTERDAM; IN HIS YOUTH A SIGNIFICANT PLAYER IN THE LITERARY (2020) (0)
Delivering 3.3V and 5V at 17W (2015) (0)
SUDDEN CARDIAC DEATH The effects of daily exercise on susceptibility to sudden cardiac death (2005) (0)
Electrocardiography first for reducing cot death (2001) (0)
Single device provides 3.3V and 5V in surface mount (2015) (0)
The Variable Light Curve of 56 Arietis (2000) (0)
21st Century Underground Steel Tank Protection Today (1997) (0)
Most Valuable Soccer Teams: clubs with a global reach extend their advantage over rivals (2010) (0)
Goethe Yearbook 15: Why Did Goethe Marry When He Did? (2008) (0)
In memoriam Alberto Zanchetti (Parma July 27, 1926 – Milan March 24, 2018) (2018) (0)
Effect of D-sotalol on the risk for ventricular fibrillation in conscious dogs with a prior myocardial infarction (1993) (0)
Goethe's Ghosts: “I'll burn my books!”: Faust(s), Magic, Media (2013) (0)
Legend: From Einfache Formen (“Simple Forms”) (2013) (0)
Experimental evaluation of antiarrhythmic drugs efficacy. (1983) (0)
Abstract 2848: Predictive Factors for Therapeutic Success in Patients With Recent-onset Paroxysmal and Persistent Atrial Fibrillation in the RecordAF Registry (2009) (0)
Inherited Cardiac Arrhythmia Syndrome: Role of Potassium Channels (2011) (0)
[The Italian Society of Cardiology has a new President]. (1999) (0)
Novel human pathological mutations (2006) (0)
[New ways to become embroiled in a medico-legal suit. Encounters of the third type between cardiologists and lawyers in the era of guidelines and of molecular biology]. (2004) (0)
[Study of preganglionic sympathetic single fibers in relation to various physiologic and pathologic stimuli]. (1969) (0)
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls (2020) (0)
Prevention of Sudden Death in Inherited Arrhythmic Disorders: The Case of the Long QT Syndrome (2011) (0)
Detection of dishomogeneity of ventricular repolarization in patients with long QT syndrome (LQTS) (1990) (0)
Post-Infarction: When and How to Use Amiodarone (2002) (0)
Abstract 11984: The KCNQ1 rs2074238 Polymorphism Is a Genetic Modifier of Cardiac Risk in Long QT Syndrome (2011) (0)
Effect of Considering the Relatives' Quality of Life in Cost-Utility Studies (2004) (0)
Gene symbol: KCNQ1. Disease: Long QT syndrome. (2008) (0)
Abstract 16181: Ranolazine Reduces the Late Recurrences of Atrial Fibrillation. An Exploratory Analysis of the Raffaello Study (2014) (0)
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases (2022) (0)
Formulating a thesis; or: chaos and cosmos (2016) (0)
Sudden infant death, long Q-T interval and long Q-T syndrome (1977) (0)
[Activity of afferent cardiac vagal fibers during experimental myocardial ischemia]. (1971) (0)
SEVERE CHRONIC STRESS OFTEN PRECEDES IDIOPATHIC VENTRICULAR FIBRILLATION (IVF) (1999) (0)
1091-223 The implantable defibrillator and the long QT syndrome: An overview of current use and outcome (2004) (0)
The impact of genetics on the long QT syndrome: myth or reality? (2023) (0)
Neonatal ECG Screening: When Timing Matters. (2020) (0)
Use of hiPSC-derived cardiomyocytes to rule out proarrhythmic effects of drugs: The case of hydroxychloroquine in COVID-19 (2022) (0)
Slower heart rates associated with lower risk of serious arrhythmic attacks in long-QT syndrome type 1 (LQT1) : abstract (2008) (0)
[Baroceptive reflex sensibility in non-anesthetized animals. Evaluation and comparison of 2 methods applicable to humans]. (1988) (0)
Clinical Clues and Experimental Evidences of the Neuro-Humoral Interpretation of Cardiac Arrhythmias (1984) (0)
Abstract 19454: Identification of Upregulated microRNAs In the Plasma of Patients with Acute Myocardial Infarction (2010) (0)
To detect the spontaneous pattern of the Brugada syndrome the Echo- and ECG-guided approach are superior to the standard method (2013) (0)
Difficult management of Jervell and Lange-Nielsen syndrome: An endless search. (2016) (0)
Abstract 18659: Electrical Stimulation of the Intact Right Cervical Vago-Sympathetic Trunk Decreases Myocardial Norepinehrine Spillover in the Setting of Sympathetic Activation (2016) (0)
Corrigendum to "Molecular genetic testing in athletes: Why and when a position statement from the Italian Society of Sports Cardiology" [International Journal of Cardiology Volume 364, 1 October 2022, Pages 169-177]. (2022) (0)
Alpha-adrenergic blockade during exercise in dogs with myocardial infarction and left stellate ganglionectomy (1980) (0)
QT Interval Prolongation asPredictor ofSuddenDeath inPatients withMyocardial Infarction (1978) (0)
[Electrophysiologic features of the modulation of ATP-dependent potassium channels]. (1995) (0)
Mechanisms of Actions of Inhaled Anesthetics (2003) (0)
Prevalence of the Bifid T Waves in Genotyped LQTS Children (1998) (0)
Syndrome du QT long congénital asymptomatique : Le patient asymptomatique (1992) (0)
Baseball as a Road to God: Seeing Beyond the Game (2013) (0)
Analysis of 23 Families (2005) (0)
Gene symbol: KCNH2. Disease: Long QT syndrome. (2008) (0)
[Measurement of QT interval in patients with myocardial infarct]. (1988) (0)
1979-2004 : 25 YEARS OF THE INTERNATIONAL REGISTRY FOR THE LONG QT SYNDROME: ITS IMPACT ON KNOWLEDGE AND CLINICAL MANAGEMENT (2005) (0)
Risk stratification for sudden cardiac death in primary electrical disorders (2018) (0)
SCN5A mutations in 442 neonates and children: Genotype-phenotype correlation and identification of higher-risk subgroups (2019) (0)
Impact of Genetics on the ClinicalManagementof Channelopathies (2019) (0)
Batch Action PoTential Analyser (BAPTA): an open source tool for automated high throughput analysis of cardiac action potentials (2023) (0)
Hemodynamic response to exercise with a new class III antiarrhythmic drug: 1-bromo-3,4,3-dibutylaminopropoxy-3-chlorobenzoyl-2-phenyl indolizine hydrochloride (LB) (1985) (0)
Heart Rate Variability: a possible tool for risk stratification in the Brugada syndrome (2013) (0)
Chronic Vagus Nerve Stimulation (CVNS) - A New Target for Treatment of Congestive Heart Failure (2008) (0)
Autonomic Nervous System: Emerging Concepts and Clinical Applications (2009) (0)
Distributed Mobile Device Based Shooter Detection Simulation (2013) (0)
COVID-19 vaccination in patients with long QT syndrome (2022) (0)
BASELINE AND CHANGE IN LIFE'S SIMPLE 7 CARDIOVASCULAR HEALTH SCORE AND RISK OF SUDDEN CARDIAC DEATH IN THE POPULATION (2023) (0)
Long QT Syndrome, a Diagnosis That Warrants Expert Opinion and Expert Centers. (2023) (0)
The 'Sicilian Gambit'. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. The Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. (1992) (0)
Abstract 2700: KCNJ2-Specific ECG Abnormalities in Type 1 Andersen-Tawil Syndrome: The Enlarged U Wave, Prolonged QU Interval and Left Ventricular Arrhythmias (2006) (0)
Neonatal Electrocardiogram 2002 (2012) (0)
Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2. (2023) (0)
Enhanced sympathetic activity during exercise in post myocardial infarction dogs at high risk for sudden death (1984) (0)
Fast Computation on the Modern Battlefield (2015) (0)
Role of vagal tone and vagal reflexes in the occurrence of malignant ventricular arrhythmias longterm after myocardial infarction (1993) (0)
When genetic screening for your patient with long QT syndrome comes back negative, don't always take a no for a no. (2012) (0)
Carbon monoxide and lethal arrhythmias. Research report, Jul 85-Jan 89 (1990) (0)
Gene symbol: KCNH2. (2007) (0)
Scopolamine Increases Vagal T_ and Vagt -, Z_ In Patients After MYocardial Infarction, (2016) (0)
SIDS: The Role of LQTS and Its Implications for Prevention of Avoidable Tragedies (2011) (0)
Dispersion of ventricular repolarization: A new marker to identify high risk patients with long QT syndrome (1993) (0)
[Long-QT caused by drugs and torsade de pointes: a genetic basis?]. (1999) (0)
Abstract 14459: Genome-Wide Association Analysis Identifies 3 Common Variants Predisposing to Brugada Syndrome, a Rare Disease With High Risk of Sudden Cardiac Death (2013) (0)
Channelopathies and Sudden Cardiac Death (2021) (0)
[The role of the neurovegetative system in the pathogenesis of sudden cardiac death]. (1979) (0)
Correction to: Long QT Syndrome (2020) (0)
Task Force 4 : Sudden cardiac death Nonpharmacologic interventions (2005) (0)
Cardiac Channelopathies and Sudden Infant Death Syndrome. In: Electrical Diseases of the Heart. Volume 2: Diagnosis and Treatment (2013) (0)
Differential response to mexiletine, catecholamines and pacing, in a cellular model mimicking the SCN5A and HERG genes defect present in the long QT syndrome (1996) (0)
Pathophysiology and Prevention of Atrial Fibrillation Current (2001) (0)
Denervation of the heart in congenital long QT and deafness. (1989) (0)
Age and gender-related differences in the congenital long QT syndrome: Findings from the international prospective study (1996) (0)
[A new experimental model for the study of arrhythmias dependent on the interaction between myocardial ischemia and sympathetic hyperactivity. I. Effects of phosphocreatinine]. (1978) (0)
Abstract 46: Guidelines Changes and Improvement of Survival to Hospital Discharge After Out-of-Hospital Cardiac Arrest: A Meta-Analysis from the Literature (2011) (0)
[Electric change of the wave T: clinical and experimental evidence of its relation to the sympathetic nervous system]. (1973) (0)
The Link Between SIDS and Long QT Syndrome: from Theory to Evidence (2002) (0)
[Idiopathic syndrome of the long QT interval--the need for a prospective study]. (1984) (0)
Symptomatic and Asymptomatic Discrimination by Single Nucleotide Polymorphisms in LQTS2 Patients: A DNA-Based Patient Stratification (2016) (0)
Analysis ofHLAandDisease Susceptibility: Chromosome6Genes andSexInfluence Long-QTPhenotype (1994) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Peter J. Schwartz?

Peter J. Schwartz is affiliated with the following schools:

Peter J. Schwartz's Academic­Influence.com Rankings

Peter J. Schwartz's Degrees

Similar Degrees You Can Earn

Why Is Peter J. Schwartz Influential?

Peter J. Schwartz's Published Works

Published Works

What Schools Are Affiliated With Peter J. Schwartz?

Peter J. Schwartz's AcademicInfluence.com Rankings